🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/11/1997 | 41,98 | 42,64 | 41,15 | 41,48 | -1,90% | 3,55% | 8.064.360 |
| 11/11/1997 | 42,13 | 42,82 | 42,13 | 42,28 | +0,14% | 1,63% | 5.512.690 |
| 10/11/1997 | 42,94 | 43,18 | 42,10 | 42,22 | -0,28% | 2,50% | 7.219.462 |
| 07/11/1997 | 41,75 | 42,67 | 41,57 | 42,34 | +0,00% | 2,64% | 8.690.854 |
| 06/11/1997 | 42,04 | 42,64 | 41,93 | 42,34 | +1,00% | 1,70% | 7.463.646 |
| 05/11/1997 | 41,98 | 42,31 | 41,57 | 41,93 | -0,35% | 1,78% | 8.598.630 |
| 04/11/1997 | 43,06 | 43,24 | 42,04 | 42,07 | -2,56% | 2,77% | 6.506.822 |
| 03/11/1997 | 43,15 | 43,36 | 42,70 | 43,18 | +1,40% | 1,52% | 6.624.408 |
| 31/10/1997 | 42,28 | 42,88 | 41,84 | 42,58 | +2,00% | 2,47% | 6.688.546 |
| 30/10/1997 | 41,98 | 43,15 | 38,47 | 41,75 | -1,34% | 11,15% | 7.623.152 |
| 29/10/1997 | 42,64 | 43,33 | 42,04 | 42,31 | +0,92% | 3,01% | 11.973.819 |
| 28/10/1997 | 39,12 | 42,94 | 39,12 | 41,93 | +3,38% | 9,76% | 23.196.432 |
| 27/10/1997 | 43,18 | 43,21 | 40,55 | 40,55 | -8,97% | 6,15% | 16.099.586 |
| 24/10/1997 | 45,68 | 45,83 | 44,46 | 44,55 | -1,19% | 3,00% | 7.328.664 |
| 23/10/1997 | 45,26 | 45,92 | 44,79 | 45,09 | -2,83% | 2,50% | 9.020.555 |
| 22/10/1997 | 46,49 | 46,67 | 45,65 | 46,40 | +0,13% | 2,18% | 4.771.334 |
| 21/10/1997 | 45,98 | 46,46 | 45,68 | 46,34 | +2,57% | 1,69% | 7.671.779 |
| 20/10/1997 | 45,44 | 45,80 | 44,46 | 45,18 | -0,07% | 2,95% | 8.732.984 |
| 17/10/1997 | 45,50 | 45,86 | 44,61 | 45,21 | -2,94% | 2,75% | 14.385.686 |
| 16/10/1997 | 48,49 | 48,49 | 46,04 | 46,58 | -4,52% | 5,04% | 15.927.923 |
| 15/10/1997 | 48,01 | 49,38 | 47,98 | 48,78 | +0,74% | 2,92% | 5.622.520 |
| 14/10/1997 | 48,01 | 48,75 | 47,68 | 48,43 | +1,56% | 2,24% | 5.616.861 |
| 13/10/1997 | 47,95 | 48,04 | 47,59 | 47,68 | +0,82% | 0,93% | 3.023.899 |
| 10/10/1997 | 47,68 | 47,92 | 47,29 | 47,29 | -1,00% | 1,31% | 4.265.150 |
| 09/10/1997 | 48,54 | 48,57 | 47,77 | 47,77 | -2,08% | 1,66% | 4.357.165 |
| 08/10/1997 | 49,11 | 49,29 | 47,83 | 48,78 | -0,18% | 2,98% | 6.487.330 |
| 07/10/1997 | 48,25 | 48,87 | 47,74 | 48,87 | +1,30% | 2,35% | 5.759.598 |
| 06/10/1997 | 48,43 | 48,43 | 48,07 | 48,25 | +0,25% | 0,74% | 4.294.704 |
| 03/10/1997 | 48,90 | 49,08 | 47,89 | 48,13 | -0,43% | 2,44% | 5.232.664 |
| 02/10/1997 | 48,07 | 48,49 | 47,50 | 48,34 | +0,93% | 2,05% | 3.200.173 |